Featured Story
CORT Investors Offered Lead Role in Corcept Therapeutics Securities Fraud Lawsuit
Investors who acquired common stock in Corcept Therapeutics Incorporated (NASDAQ: CORT) between October 31, 2,024, and December 30, 2,025, are being reminded of a critical deadline: April 21, 2,026. This date marks the final opportunity for eligible shareholders to seek appointment as lead plaintiff...
48 min ago